Difference between revisions of "Clopidogrel (Plavix)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "or the prescribing information<ref name="insert"></ref>." to "or the prescribing information.<ref name="insert"></ref>")
(updated content)
Line 1: Line 1:
 
==General information==
 
==General information==
Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y12 class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.<ref name="insert">[http://products.sanofi.us/PLAVIX/plavix.pdf Clopidogrel (Plavix) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/clopidogrel.pdf Clopidogrel (Plavix) package insert (locally hosted backup)]</ref><ref>[http://www.plavix.com Plavix manufacturer's website]</ref>
+
Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y12 class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.<ref name="insert">[http://products.sanofi.us/PLAVIX/plavix.pdf Clopidogrel (Plavix) package insert]</ref><ref>[[Media:Clopidogrel.pdf | Clopidogrel (Plavix) package insert (locally hosted backup)]]</ref><ref>[http://www.plavix.com Plavix manufacturer's website]</ref>
 
<br>Route: PO
 
<br>Route: PO
 
<br>Extravasation: n/a
 
<br>Extravasation: n/a
Line 13: Line 13:
 
==References==
 
==References==
 
<references/>
 
<references/>
 +
 +
[[Category:Drug index]]
 +
[[Category:Hematology medications]]
 +
[[Category:Hemostasis medications]]
 +
[[Category:P2Y12 ADP inhibitors]]

Revision as of 15:52, 8 October 2012

General information

Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y12 class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.[1][2][3]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

References